June 2023
Exploring the journey of Heart Transplantation - where are we in 2023?
Dr. Cornelia Margineanu
Bucharest, RO
Dr. Tuvia Ben Gal
Petah Tikva, IL
Throughout this podcast, the expert Dr. Tuvia Ben Gal shares a wealth of knowledge, drawing from years of experience and expertise in the field regarding indications, outcomes, specific management and also, valuable practical advice.
May 2023
Insights from late breaking clinical trials from the Heart Failure Congress 2023, Prague, CZ
Dr. Antonio Cannata
London, UK
Dr. Jozine ter Maaten
Groningen , NL
Dr. Sotiria Liori
Athens, GR
Dr. Jasper Brugts
Rotterdam, NL
Prof. John Cleland
Glasgow, UK
Dr. Ross Campbell
Glasgow, UK
Dr. Francesca Musella
London, UK
Dr. Jeroen Dauw
Ghent , BE
This podcast discusses the results of four late breaking clinical trials presented at the Heart Failure congress 2023 in Prague, Czech. First, dr. Brugts shares the results of the MONITOR-HF trial, an open-label, randomized trial showing that haemodynamic monitoring using a cardioMEMS device, significantly improved quality of life and reduced heart failure hospitalizations in patients with moderate-to-severe heart failure. This trial was simultaneously published in the Lancet (Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet). Second, dr. Cleland walks us through a population study from the greater Glasgow area that found that use of loop diuretics in patients without a diagnosis of heart failure was associated with poor outcomes. He consequently discusses possible explanations and clinical consequences. Third, dr. Campbell shares the results of the DAPA-RESIST trial, that found that in patients with diuretic resistance, dapagliflozin was not superior to metolazone at relieving congestion (Dapagliflozin versus metolazone in heart failure resistant to loop diuretics | European Heart Journal | Oxford Academic (oup.com)). Fourth, dr. Dauw discusses the results of the ENACT-HF trial where a strategy of natriuresis guided therapy as recommended by the HF guidelines, in an open label, sequential roll-out (first 10 patients standard of care, followed by 10-30 patients in the natriuresis arm), was shown to improve natriuresis and reduced length of hospital stay. No effect on change in congestion score or in-hospital mortality was observed. The podcast is concluded with a brief discussion of some HFA Young highlights at the congress.
April 2023
A deep dive into translational science in Heart Failure. Lessons learnt and future perspectives.
Dr. Antonio Cannata
London, UK
Prof. Mauro Giacca
London, UK
In this episode, Dr Cannata interviews Prof Giacca on the present and future perspectives of translational science in Heart Failure. A deep dive into the translational world with a view on the research of the next 30 years.
March 2023
Shock Talk: Epidemiology, pathophysiology and contemporary management of cardiogenic shock.
Dr. Sotiria Liori
Athens, GR
Prof. Ovidiu Chioncel
Bucarest, RO
In this HFA Cardio Talk, Dr. Sotiria Liori, member of the HFA Young Committee, interviews Prof. Ovidiu Chioncel on cardiogenic shock. The podcast delves into the challenges and latest advancements in the diagnosis and management of this complex condition, providing valuable insights for clinicians and researchers. Prof. Chioncel shares his extensive knowledge on the importance of hemodynamic monitoring, the use of mechanical circulatory support devices, and other therapeutic interventions in the management of patients with cardiogenic shock. With his practical tips and tricks, Prof. Chioncel offers guidance for optimizing patient outcomes and enhancing the quality of care for this high-risk population.
February 2023
Advanced heart failure: definition, diagnostic work-up, tips and tricks - introduction to the first HFA Advanced Heart Failure course.
Dr. Mateusz Sokolski
Wroclaw, PL
Prof. Finn Gustafsson
Copenhagen, DK
In this HFA Cardio Talk, Finn Gustafsson, Professor of Cardiology at the University of Copenhagen, director of the advanced heart failure, transplantation and mechanical circulatory support program at Rigshospitalet in Copenhagen, Denmark and member of the HFA Board is interviewed by Dr. Mateusz Sokolski, from Wroclaw Medical University in Poland, member of the HFA Young Committee. The podcast is related to the HFA Advanced Heart Failure course 2023, discussing its aims and rationale. Moreover, the podcast covers challenges of the disease and provides tips and tricks for the management of patients with advanced heart failure and long-term mechanical circulatory support.
January 2023
Diagnosis and management of myocarditis: current state and future perspectives
Dr. Emanuele Bobbio
Gothenburg, SW
Prof. Carsten Tschoepe
Berlin, DE
In this HFA Cardio Talk, Prof. Tschöpe, chair of the HFA Committee on "Cardiomyopathies, Myocarditis & Pericardial Disease", is interviewed by Dr. Bobbio, member of the HFA Young Committee, on myocarditis. This podcast will walk us through the diagnostic and therapeutic challenges of myocarditis, explaining the role of biomarkers, imaging techniques and histology in defining different subtypes of myocarditis and their prognostic and therapeutic implications. Prof. Tschöpe will also provide tips and tricks for the management of patients presenting with acute, fulminant forms of myocarditis.
December 2022
Emerging key role of patients profiling in heart failure patients management
Dr. Francesca Musella
Naples, IT
Dr. Brenda Moura
Porto, PT
In this HFA Cardio Talk, Dr. Francesca Musella interviews Dr. Brenda Moura on the emerging role of patients´profiling in Heart Failure. The podcast starts with an overview of this emerging concept introduced by current HF guidelines, and then addresses the main benefits and practical repercussions of following this approach in clinical practice. In conclusion, the podcast underlies how tailoring HF medications prescription to each patient specific profile and personal tolerability may guide physicians to both HF medications prescription and up-tritation in real world scenarios.
November 2022
Valvular heart disease in patients with heart failure
Dr. Daniela Tomasoni
Brescia, IT
Dr. Marianna Adamo
Brescia, IT
In this HFA Cardio Talk, Dr. Daniela Tomasoni interviews Dr.Marianna Adamo on valvular heart disease in heart failure. The podcast starts with an epidemiological overview and then addresses the main pathophysiological mechanisms of valvular heart disease in patients with heart failure. It also discusses current recommendations regarding the treatment of mitral regurgitation. In conclusion, dr. Adamo will guide us through the new available percutaneous devices for the treatment of tricuspid regurgitation.
October 2022
The changing role of Cardiovascular Magnetic Resonance in Heart Failure patients
Dr. Jessica Artico
London, UK
Prof. Chiara Bucciarelli-Ducci
London, UK
In this HFA Cardio Talk, Prof Chiara Bucciarelli-Ducci, interviewed by Dr Jessica Artico, will discuss the enhanced role of Cardiovascular Magnetic Resonance in Heart Failure Patients and in the new HF guidelines. It will walk us through the advancements of this imaging technique, what can possibly change after the results of recent HF trials, as well as the role of stress CMR and the future perspectives of CMR for a HF specialist.
September 2022
Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World
Dr. Angela Massouh
Beirut, Lebanon
Dr. Loreena Hill
Belfast, Ireland
In this HFA Cardio Talk, Dr. Angela Massouh interviews Dr. Loreena Hill on living with a left ventricular assist device, and lessons learned from around the globe. This podcast addresses the experiences of patients living with a left ventricular assist device and their informal caregivers. It will also highlight clinical aspects of self-care and how international multidisciplinary healthcare providers can do better to assist this vulnerable group.
July 2022
Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?
Dr. Emma Louise Robinson
Aurora, Colorado, U.S
Prof. Luisa Mestroni
Aurora, Colorado, U.S
In this HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast discusses current approaches to diagnosis, treatment options and support for patients and families of inherited cardiomyopathy as well as how advances in gene editing have transformed translational research, understanding of disease mechanisms and prospects for clinical care.
June 2022
HFpEF – The enigma of Heart Failure
Assist. Prof. Markus Wallner
Graz, Austria
Prof. Rudolf de Boer
Groningen, the Netherlands
This podcast discusses the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HFA Young Committee, and will walk us through the diagnostic and therapeutic challenges of HFpEF and provide tips and tricks for the management of patients with HFpEF.
May 2022
Insights and prospects from the Heart Failure Congress 2022, Madrid, Spain
Dr. Antonio Cannata
London, UK
Dr. Mateusz Sokolski,
Wrocław, Poland
Dr. Otilia Țica
Oradea, Romania
Prof. Finn Gustafsson
Copenhagen, Denmark
Prof. John Cleland
London, UK
Prof Theresa McDonagh
London, UK
Prof. Gianluigi Savarese
Stockholm, Sweden
Prof Carolyn Lam
Singapore
Prof. Marco Metra
Brescia, Italy
This podcast discusses the insights and highlights shared by key-leaders in heart failure during the annual meeting: Heart Failure Congress, held in Madrid, Spain. Prof. Gustafson offers an overview on advanced heart failure therapies and the role of MCS (mechanical circulatory support). Prof Cleland debates when should we attempt revascularisation in heart failure patients. Prof McDonagh shares the updates and changes in the implementation of the HF guidelines in the last year, since their release. Prof Savarese highlights the best scientific statement of this year, the universal definition of Heart Failure. Prof Lam provides key message and trials in HF and also underlines the sex-differences in these patients. Prof Metra discusses the pillars and future perspectives of HF and the importance of education.
April 2022
Tips and tricks in interpretation of clinical trials
Prof. Petar M. Seferović
Belgrade, Serbia
Dr. Ivan Milinković
Belgrade, Serbia
The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment
March 2022
Implementing the use of HF treatments in clinical practice
Prof. Gianluigi Savaresse
Stockholm, Sweden
Dr. Otilia Țica
Oradea, Romania
This podcast discusses the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HFA Young committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.
February 2022
The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives
Giuseppe Rosano
London, UK
Dr. Antonio Cannata
London, UK
This podcast discusses the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.
January 2022
Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines
Prof. Ewa A. Jankowska
Wroclaw, Poland
Mateusz Sokolski
Wroclaw, Poland
The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HFA Young Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.
Our mission: To reduce the burden of cardiovascular disease.